Please assess the completion status of the following clinical trial:

Trial Title: Dydrogesterone Versus Intravaginal Progesterone in the Luteal Phase Support

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* routine ovulation induction protocol with GnRH agonist~* less than three prior IVF cycles~* at least three aspirated oocytes~* BMI \<35 kg/m2~* age \<45 years~Exclusion Criteria:~* history of dysfunctional uterine bleeding~* acute urogenital disease~* recurrent miscarriage~* previous allergic reactions to a progesterone products

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 45 Years
- Healthy Volunteers: f

Study Arms:
- Oral dydrogesterone (Type: ACTIVE_COMPARATOR): Study group receiving 2x10mg of oral dydrogesterone until a pregnancy test or in the case of pregnancy until 10 week.
- Crinone 8% vaginal gel (Type: ACTIVE_COMPARATOR): Control group is receiving vaginal gel, 1x90mg, until a pregnancy test or in the case of pregnancy until 10 week.

Based on this trial design, predict the completion outcome and termination type (if applicable).